Histidine Oral Supplementation as a Therapeutic Modality for Alzheimer's Disease

Clinical trial NCT06169826 · WITHDRAWN

Trial details

NCT number: NCT06169826
Sponsor: Wake Forest University Health Sciences
Status: WITHDRAWN
Phase: Phase 4
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2025-04-01
Primary completion: 2026-04-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.